Iadademstat Clinical Trials (2026): 8 Studies for Acute Myeloid Leukemia & Acute Myeloid Leukemia Refractory

Where to Participate: All Iadademstat Trial Sites in the U.S. (54 sites across 22 states)

Every actively recruiting Iadademstattrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Iadademstat clinical trials at a glance: phase × recruitment status

Recruiting Iadademstat clinical trials (5)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Iadademstat clinical trials by indication

Terminated and withdrawn Iadademstat trials (3)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

• NCT06661915suspendedA Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
• NCT06514261suspendedTesting the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
• NCT05420636terminatedIadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

All Iadademstat trials (8)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Iadademstat clinical trials: frequently asked questions

How many Iadademstat clinical trials are there?

8 Iadademstat clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 5 are actively recruiting participants.

Are Iadademstat clinical trials recruiting in 2026?

Yes — 5 Iadademstat trials are actively recruiting in 2026, with 54 U.S. sites across 22 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Iadademstat being studied for?

Iadademstat is being studied for Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Blast Phase Myeloproliferative Neoplasm, Essential Thrombocythemia and 13 more. The trials are grouped by indication on this page.

What phase is Iadademstat in?

Iadademstat clinical trials span 2 Phase 2, 5 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Iadademstat clinical trials?

The lead sponsor across the most Iadademstat trials is National Cancer Institute (NCI), with 5 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Iadademstatas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 16, 2026.